Related Experiment Video
Updated: Dec 27, 2025
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
miR-532-3p inhibits osteogenic differentiation in MC3T3-E1 cells by downregulating ETS1
Qingxin Fan1, Yuqiao Li2, Qiang Sun3
1Tianjin Medical University, Tianjin, China; Department of Spinal Surgery, Tianjin Union Medical Center, Tianjin, China.
Background:
Many studies had identified that MicroRNAs (miRNAs) could affect bone metabolism by regulating the expression of various proteins. This study explored the effect and mechanism of miR-532-3p on osteogenic differentiation.
Methods:
We analyzed the content of miR-532-3p in osteoporosis patients, osteoporosis rats, and osteogenic induced MC3T3-E1 cells. MiR-532-3p mimic or inhibitor utilized to alter intracellular miR-532-3p content. MTT method executed to detect the effect of miR-532-3p on osteoblast proliferation. Real-time qPCR, Western blot, alkaline phosphatase staining, and alizarin red staining utilized to ascertain the influence of miR-532-3p on osteogenic differentiation. Then, databases and a dual-luciferase reporter gene assay used to verify the target of miR-532-3p. Furthermore, the lentiviral vector was utilized to overexpress interesting target gene expression and checked whether the target gene was involved in the regulation of osteogenic differentiation by miR-532-3p.
Results:
MiR-532-3p expression boosted in low bone mineral density (BMD) patients and rats. In MC3T3-E1 cells, miR-532-3p expression gradually decreased as osteogenic induction matures. MiR-532-3p mimic negatively regulated succinate dehydrogenase (SDH) activity, alkaline phosphatase (ALP) activity, mineralization ability, the osteogenic-associated gene (Col1A1, Runx2, ALP, OPN, and OCN) and E-26 transformation specific-1 (ETS1) expression of MC3T3-E1 cells. Things are the opposite of the miR-532-3p inhibitor. ETS1 identified as the miR-532-3p target gene, and miR-532-3p could inhibit its expression. Besides, improved ETS1 expression could rescue the suppressive effect of miR-532-3p mimic on osteogenic differentiation.
Conclusion:
miR-532-3p can suppress osteogenic differentiation by downregulating ETS1 expression.
Insights
MicroRNA-532-3p (miR-532-3p) suppresses bone formation by reducing ETS1 expression. This finding offers new insights into osteoporosis mechanisms and potential therapeutic targets for bone metabolism regulation.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- MicroRNAs (miRNAs) play a crucial role in regulating bone metabolism by controlling protein expression.
- Understanding the specific roles of miRNAs, such as miR-532-3p, is vital for deciphering bone health mechanisms.
Purpose of the Study:
- To investigate the effect of miR-532-3p on osteogenic differentiation.
- To elucidate the underlying molecular mechanism of miR-532-3p in regulating bone formation.
Main Methods:
- Analysis of miR-532-3p expression in osteoporosis models and osteogenic cells.
- Manipulation of miR-532-3p levels using mimics and inhibitors.
- Assessment of osteoblast proliferation, activity, and mineralization.
- Identification of miR-532-3p targets using bioinformatics and luciferase assays.
- Validation of target gene function in osteogenic differentiation.
Main Results:
- miR-532-3p expression was elevated in low bone mineral density (BMD) patients and rats, and decreased during osteogenic differentiation.
- miR-532-3p mimic inhibited osteoblast activity, mineralization, and expression of key osteogenic genes (Col1A1, Runx2, ALP, OPN, OCN) and ETS1.
- ETS1 was identified as a direct target of miR-532-3p, with miR-532-3p negatively regulating its expression.
- Overexpression of ETS1 rescued the inhibitory effects of miR-532-3p on osteogenic differentiation.
Conclusions:
- miR-532-3p acts as a suppressor of osteogenic differentiation.
- The mechanism involves the downregulation of ETS1 by miR-532-3p.
- These findings highlight miR-532-3p as a potential regulator in bone metabolism and osteoporosis.
